Long-Term Follow Up Study for AMD3100 Patients

Long-Term Observational Follow-Up Study of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 (240 MCG/KG) Plus G-CSF (10 MCG/KG) Versus G-CSF (10 MCG/KG) Plus Placebo to Mobilize and Collect >/= 6 x 10^6 CD34+ Cells/KG in Multiple Myeloma Patients for Autologous Transplantation

Sponsor(s)

Genzyme Corporation

Principal Investigator(s)Jonathan L Kaufman, MD
Dates11/16/2007 - 11/16/2012